| Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE initiative JM Franklin, E Patorno, RJ Desai, RJ Glynn, D Martin, K Quinto, A Pawar, ... Circulation 143 (10), 1002-1013, 2021 | 237 | 2021 |
| Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials SV Wang, S Schneeweiss, JM Franklin, RJ Desai, W Feldman, EM Garry, ... Jama 329 (16), 1376-1385, 2023 | 115 | 2023 |
| Risk of admission to hospital for serious infection after initiating tofacitinib versus biologic DMARDs in patients with rheumatoid arthritis: a multidatabase cohort study A Pawar, RJ Desai, N Gautam, SC Kim The Lancet Rheumatology 2 (2), e84-e98, 2020 | 54 | 2020 |
| Updating International Classification of Diseases 9th Revision to 10th Revision of a claims-based frailty index N Gautam, L Bessette, A Pawar, R Levin, DH Kim The Journals of Gerontology: Series A 76 (7), 1316-1317, 2021 | 37 | 2021 |
| Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study BT Bateman, S Hernandez-Diaz, L Straub, Y Zhu, KJ Gray, RJ Desai, ... Bmj 372, 2021 | 34 | 2021 |
| Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data JM Paik, E Patorno, M Zhuo, LG Bessette, C York, N Gautam, DH Kim, ... Pharmacoepidemiology and drug safety 31 (4), 467-475, 2022 | 23 | 2022 |
| Regulatory authority and clinical acceptability: Physicians' responses to regulatory drug safety warnings AL Bhasale, A Sarpatwari, W Lipworth, M Møllebæk, EJ McEwin, ... British Journal of Clinical Pharmacology 88 (2), 713-722, 2022 | 10 | 2022 |
| Changes in utilization of generic angiotensin receptor blockers following product recalls in the United States RJ Desai, A Sarpatwari, N Gautam, J Lii, MA Fischer, JJ Gagne JAMA 323 (1), 87-89, 2020 | 9 | 2020 |
| Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platform K Wing, DJ Grint, R Mathur, HP Gibbs, G Hickman, E Nightingale, ... International Journal of Epidemiology 51 (6), 1745-1760, 2022 | 8 | 2022 |
| SAS programs-claims-based frailty index DH Kim, N Gautam NIA, trans. V10 ed: Harvard Dataverse, 2020 | 7 | 2020 |
| PDB128 Reduced healthcare utilization in patients using empagliflozin: an interim analysis from the empagliflozin comparative effectiveness and safety (EMPRISE) study M Najafzadeh, A Pawar, A Deruaz-Luyet, KG Brodovicz, A Ustyugova, ... Value in Health 22, S161, 2019 | 5 | 2019 |
| The Aetion Coalition to Advance Real‐World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology D Merola, U Campbell, N Gautam, A Rubens, S Schneeweiss, SV Wang, ... Clinical Pharmacology & Therapeutics 113 (6), 1217-1222, 2023 | 3 | 2023 |
| Risk of Malignant Melanoma and Nonmelanoma Skin Cancer in Rheumatoid Arthritis Patients Initiating Methotrexate Versus Hydroxychloroquine: a cohort study H Lee, SK Chen, N Gautam, SM Vine, M He, RJ Desai, ME Weinblatt, ... Clinical and experimental rheumatology 41 (1), 110, 2023 | 3 | 2023 |
| Healthcare resource utilization among empagliflozin initiators with and without cardiovascular disease versus DPP4i in a commercially-insured routine care population: an … M Najafzadeh, A Pawar, S Schneeweiss, A Déruaz-Luyet, K Brodovicz, ... Circulation 140 (Suppl_1), A13655-A13655, 2019 | 2 | 2019 |
| P5003 Reduced healthcare utilization in routine care initiators of empagliflozin with and without heart failure: interim analysis from the EMPagliflozin compaRative … A Pawar, E Patorno, A Deruaz-Luyet, K Brodovicz, A Ustyugova, ... European Heart Journal 40 (Supplement_1), ehz746. 0181, 2019 | 2 | 2019 |
| Healthcare costs and medication burden in routine care initiators of empagliflozin: a first analysis from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study A Pawar, E Patorno, A Déruaz-Luyet, KG Brodovicz, A Ustyugova, ... Diabetes 68, 2019 | 2 | 2019 |
| Predicting fall risks in older adults with atrial fibrillation KJ Lin, A Pawar, N Gautam, DH Kim PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 297-298, 2020 | 1 | 2020 |
| Reduced healthcare utilization in routine care initiators of empagliflozin with and without heart failure: interim analysis from the EMPagliflozin compaRative effectIveness and … A Pawar, E Patorno, A Deruaz‐Luyet, K Brodovicz, A Ustyugova, ... Eur Heart J 40, 2019 | 1 | 2019 |
| Safety of Intravenous Pantoprazole Sodium in Pediatric Patients Aged 1 Month to< 1 Year: A Real-World Retrospective Cohort Study S Gandhi, B Taylor, L Rubens, N Gautam, N Sherman, K Chittuluru, ... Therapeutic Innovation & Regulatory Science 58 (1), 166-174, 2024 | | 2024 |
| Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platform (vol 51, pg … K Wing, DJ Grint, R Mathur, HP Gibbs, G Hickman, E Nightingale, ... INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2023 | | 2023 |
